Literature DB >> 17508256

A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma.

Masahiro Kai1, Kazuo Chijiiwa, Jiro Ohuchida, Motoaki Nagano, Masahide Hiyoshi, Kazuhiro Kondo.   

Abstract

The aim of this study was to evaluate the results of our series of 90 operations for gallbladder carcinoma according to the Japanese Society of Biliary Surgery (JSBS) classification system and to clarify the appropriate surgical strategy for advanced gallbladder carcinoma based on the depth of primary tumor invasion and lymph node metastasis. Generally, only a surgical resection can achieve a prognostic improvement of the advanced gallbladder carcinoma. The survival of patients with this neoplasm depends strictly on the depth of histological primary tumor invasion and lymph node metastasis. A retrospective analysis was conducted on 90 patients from 1990 to 2004 who underwent a surgical resection of gallbladder carcinoma. The factors influencing survival were examined. Thirty-nine patients with palliative treatment (not resected cases), which was diagnosed as T3 or T4 by preoperative imagings, were also included in this study. The significance of the variables for survival was examined by the Kaplan-Meier method and the log-rank test followed by multivariate analyses using Cox's proportional hazard model. Portal invasion, lymph node metastasis, the surgical margin (+ vs. -) and the final curability (fCurA, B vs. C) were all found to be independent prognostic factors in the multivariate analysis. In pT2 gallbladder carcinoma, a better survival was achieved in an aggressive surgical approach, in order of a S4a+S5 hepatic resection, an extended cholecystectomy and a cholecystectomy. In pT3 and pT4, although radical extended surgery did not provide the opportunity for good survival even after lobectomy of the liver, the survival of patients with curative surgery was statistically better than in those without curative surgery. In addition, the nodal involvement of pN1 to pN2 was better than that with pN3. A S4a+S5 hepatectomy, therefore, appears to be adequate for the treatment of pT2 gallbladder carcinoma. Even in patients with pT3 and pT4 gallbladder carcinoma, long-term survival can be expected by an operation with a tumor-free surgical margin. The role of radical surgery, however, is considered to be limited in patients with pN3 lymph node metastasis.

Entities:  

Mesh:

Year:  2007        PMID: 17508256     DOI: 10.1007/s11605-007-0181-4

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  36 in total

1.  Early gallbladder carcinoma does not warrant radical resection.

Authors:  T Wakai; Y Shirai; N Yokoyama; S Nagakura; H Watanabe; K Hatakeyama
Journal:  Br J Surg       Date:  2001-05       Impact factor: 6.939

2.  Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Maeda; S Kondo; A Yasui; S Shionoya
Journal:  Hepatogastroenterology       Date:  1991-04

3.  Radical resection improves survival for patients with pT2 gallbladder carcinoma.

Authors:  P E Wise; Y Y Shi; M K Washington; W C Chapman; J K Wright; K W Sharp; C W Pinson
Journal:  Am Surg       Date:  2001-11       Impact factor: 0.688

Review 4.  Long-term results after resection for gallbladder cancer. Implications for staging and management.

Authors:  D L Bartlett; Y Fong; J G Fortner; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

5.  Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection.

Authors:  Kengo Yoshimitsu; Hiroshi Honda; Kenji Shinozaki; Hitoshi Aibe; Toshiro Kuroiwa; Hiroyuki Irie; Kazuo Chijiiwa; Yoshiki Asayama; Kouji Masuda
Journal:  AJR Am J Roentgenol       Date:  2002-08       Impact factor: 3.959

6.  Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma.

Authors:  Itaru Endo; Hiroshi Shimada; Atsushi Takimoto; Yoshiro Fujii; Yasuhiko Miura; Mitsutaka Sugita; Daisuke Morioka; Hideki Masunari; Kuniya Tanaka; Hitoshi Sekido; Shinji Togo
Journal:  World J Surg       Date:  2004-06-04       Impact factor: 3.352

7.  Impact of recent advances in hepatobiliary imaging techniques on the preoperative diagnosis of carcinoma of the gallbladder.

Authors:  K Chijiiwa; K Sumiyoshi; F Nakayama
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

8.  Carcinoma of the gallbladder: an appraisal of surgical resection.

Authors:  K Chijiiwa; M Tanaka
Journal:  Surgery       Date:  1994-06       Impact factor: 3.982

9.  Hepatopancreatoduodenectomy for advanced gallbladder carcinoma.

Authors:  S Nakamura; R Nishiyama; Y Yokoi; A Serizawa; Y Nishiwaki; H Konno; S Baba; H Muro
Journal:  Arch Surg       Date:  1994-06

Review 10.  Gallbladder cancer: laparoscopic and classic cholecystectomy.

Authors:  N Darabos; R Stare
Journal:  Surg Endosc       Date:  2003-11-21       Impact factor: 4.584

View more
  32 in total

1.  Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2010-02-23       Impact factor: 4.584

2.  Comparative analysis between clinical outcomes of primary radical resection and second completion radical resection for T2 gallbladder cancer: single-center experience.

Authors:  Seong Yeon Cho; Sang-Jae Park; Seong Hoon Kim; Sung-Sik Han; Young-Kyu Kim; Kwang-Woong Lee
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

3.  Ten-year experience in the management of gallbladder cancer from a single hepatobiliary and pancreatic centre with review of the literature.

Authors:  Seok L Ong; Giuseppe Garcea; Sarah C Thomasset; Christopher P Neal; David M Lloyd; David P Berry; Ashley R Dennison
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

4.  Prognostic factors of patients with advanced gallbladder carcinoma following aggressive surgical resection.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hironori Kobayashi; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2011-03-10       Impact factor: 3.452

Review 5.  Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis.

Authors:  Kui Sun Choi; Sae Byeol Choi; Pyoungjae Park; Wan Bae Kim; Sang Yong Choi
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

6.  Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.

Authors:  Stefan Buettner; Georgios Antonios Margonis; Yuhree Kim; Faiz Gani; Cecilia G Ethun; George A Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2016-08-05       Impact factor: 5.344

Review 7.  Gallbladder cancer, treatment failure and relapses: the peritoneum in gallbladder cancer.

Authors:  Charlotte Maplanka
Journal:  J Gastrointest Cancer       Date:  2014-09

8.  Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary?

Authors:  Sae Byeol Choi; Hyung Joon Han; Wan Bae Kim; Tae Jin Song; Sung Ock Suh; Sang Yong Choi
Journal:  Langenbecks Arch Surg       Date:  2013-09-21       Impact factor: 3.445

9.  The improvement of surgical treatment for patients with gallbladder cancer: analysis of 208 consecutive cases over the past decade.

Authors:  Chang Ming Shen; Guang Cai Niu; Wei Cui; Hui Kai Li; Qiang Li
Journal:  J Gastrointest Surg       Date:  2012-10-12       Impact factor: 3.452

10.  Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma.

Authors:  Motoaki Nagano; Kinta Hatakeyama; Masahiro Kai; Hajime Nakamura; Junji Yodoi; Yujiro Asada; Kazuo Chijiiwa
Journal:  HPB (Oxford)       Date:  2012-06-08       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.